Market Place
Sourcing Support
All News #Library
Biotech
Monopar Reports 2025 Financial Results And Business Update
27 Mar 2026 //
GLOBENEWSWIRE
Monopar Reveals Enhanced Copper Balance In Wilson Disease
09 Nov 2025 //
GLOBENEWSWIRE
Monopar Therapeutics Announces $40 Million Public Offering Pricing
20 Dec 2024 //
GLOBENEWSWIRE
Monopar Doses First Patient with MNPR-101-Lu Radiopharmaceutical
05 Dec 2024 //
GLOBENEWSWIRE
Monopar to Present at Piper Sandler Healthcare Conference
03 Dec 2024 //
GLOBENEWSWIRE
Monopar Therapeutic Report Q3 2024 Financial Results & Developments
08 Nov 2024 //
GLOBENEWSWIRE
Monopar Therapeutics Announces Closes $19.2 Million Offering
30 Oct 2024 //
GLOBENEWSWIRE
Monopar Therapeutics Proposes Another Common Stock Offering
28 Oct 2024 //
#N/A
Monopar Therapeutics Announces $19.2M Public Offering
28 Oct 2024 //
#N/A
Monopar Initiates Trial Of uPAR-Targeted Therapy In Cancers
07 Oct 2024 //
GLOBENEWSWIRE
Monopar MNPR-101-RIT Abstract Accepted as Top Oral Presentation at EANM’24
25 Jun 2024 //
GLOBENEWSWIRE
Monopar Files Patent Protecting MNPR-101 Radiopharma Optimization Findings
16 Apr 2024 //
GLOBENEWSWIRE
Monopar Initiates Radiopharma Phase 1 Clinical Trial for MNPR-101-Zr
10 Apr 2024 //
GLOBENEWSWIRE
Monopar Announces Positive Data for its MNPR-101 Program
05 Mar 2024 //
GLOBENEWSWIRE
Monopar Provides Update on MNPR-101-Zr Radiopharma Clinical Trial
27 Feb 2024 //
GLOBENEWSWIRE
Monopar Announces Promising Preclinical Data for its MNPR-101
22 Feb 2024 //
GLOBENEWSWIRE
Monopar Receives Clearance to Proceed with Phase 1 Trial of MNPR-101-Zr
20 Feb 2024 //
GLOBENEWSWIRE
Monopar Announces MNPR-101 Collaboration with National University of Singapore
11 Jul 2023 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.